Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Completed 7Terminated 3Withdrawn 2Unknown 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 3Nausea 3Vomiting 2Neoplasm Metastasis 2Triple Negative Breast Neoplasms 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Gynecologic Cancer 1Carcinoma 1

Interventions

Gemcitabine 34pembrolizumab 27Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Ondansetron × Clear all
NCT00285051 2020-12-23

Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy

Rafa Laboratories

Phase 2 Terminated
6 enrolled

Nausea, Neoplasms, Vomiting

NCT00588835 2020-11-30

ACE

Radboud University Medical Center

Phase 4 Terminated
20 enrolled

Nausea, Neoplasms

NCT00609765 2017-03-23

Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Terminated
1 enrolled 3 charts
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡